PMID: 36118519 Kaohsiung J Med Sci Dihydroartemisinin enhances gefitinib cytotoxicity against lung adenocarcinoma cells by inducing ROS-dependent apoptosis and ferroptosis
[IGF-1a new risk factor for coronary atherosclerosis] [PMID: 17165168] Laboratory literature summary: [IGF-1a new risk factor for coronary atherosclerosis]
At Livealth Biopharma, we believe that Health is Wealth and are dedicated to providing high-quality pharmaceutical solutions across 65+ countries, with product registrations in 45 nations
A substantial proportion of patients treated with tirzepatide achieve near normoglycemia and weight loss approaching thresholds previously associated with bariatric surgery
Hormonal Modulation Retas unique ability to interact with multiple receptor types provides a framework for studying hormonal cross-talk, especially how GLP-1, GIP, and glucagon signaling affect one another in metabolic tissues
Anaheim IV Therapy, a division of Anaheim Medical Group, specializes in providing intravenous treatments that deliver essential vitamins, minerals, and fluids directly into your bloodstream